Valuation: Acarix AB

Market Cap 302M 31.15M 27.32M 25.31M 23.29M 44.04M 2.98B 44.9M 118M 1.46B 117M 114M 5.06B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 302M 31.15M 27.32M 25.31M 23.29M 44.04M 2.98B 44.9M 118M 1.46B 117M 114M 5.06B EV / Sales 2026 *
15.8x
EV / Sales 2027 * 4.34x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week-0.98%
Current month-0.39%
1 month-0.20%
3 months-11.36%
6 months-2.50%
Current year-5.41%
1 week 0.24
Extreme 0.2435
0.26
1 month 0.24
Extreme 0.242
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.47
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-0.98%-38.32%-55.60% 31.29M
+3.10%+8.53%+18.75%-20.16% 17.28B
-2.03%-7.63%+11.71%+93.03% 1.68B
-4.13%-2.56%-39.22%-79.96% 1.25B
+0.40%-6.06%-32.83%+25.48% 1.06B
-1.70%-3.89%-30.46%-54.61% 626M
-0.21%-4.95%-39.99%-56.10% 555M
-1.72%+1.72%+37.77%-53.19% 466M
+1.60%+1.44%-54.22%-59.51% 380M
0.00%-3.49%-22.77%-25.59% 342M
Average -0.40%-0.19%-18.96%-28.62% 2.37B
Weighted average by Cap. +1.71%+4.66%+8.74%-16.37%

Financials

2026 *2027 *
Net sales 19.1M 1.97M 1.73M 1.6M 1.47M 2.79M 189M 2.84M 7.49M 92.72M 7.41M 7.25M 320M 69.5M 7.18M 6.3M 5.83M 5.37M 10.15M 687M 10.35M 27.26M 337M 26.95M 26.37M 1.17B
Net income -28.9M -2.98M -2.62M -2.42M -2.23M -4.22M -286M -4.3M -11.33M -140M -11.21M -10.96M -485M 2.4M 248K 217K 201K 185K 350K 23.73M 357K 941K 11.65M 931K 910K 40.24M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
14/07/26 SEK 0.2535 -0.20% 142,079
10/07/26 SEK 0.2540 -1.17% 80,519
09/07/26 SEK 0.2570 +0.39% 770,882
08/07/26 SEK 0.2560 +2.40% 838,207
07/07/26 SEK 0.2500 -2.34% 1,026,959

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock